Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund,
Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

AI-enabled precision health tools can identify potential risks and suggest preventative interventions.

MEDIA7: You have a long career experience in diverse fields ranging from teaching physics and mathematics to being a Data Scientist Leader. How has all this experience helped you play your current role at Oppioo?
ANNA BAECKLUND:
My diverse set of experiences has helped a lot working with Oppioo; all from product development, to data handling, and to pitching to investors. After receiving my MSc in engineering physics, I worked as a quantitative analyst and data scientist in finance for several years before starting as head of data science at a major Swedish retail firm and CTO at Oppioo. As a result, I have a solid knowledge of data analysis as well as handling personal data and security issues – which is important not only in finance and retail but also in MedTech. As technology focuses more on integrating applications, processes, artificial intelligence and the Internet of Things, a CTO must follow the frontier of big data, streaming analytics, and cloud technology to remain innovative and stay competitive.Diverse skills allow you to think about specific problems in a different and often more strategic way. By being able to look at a problem from different angles and draw on a wealth of (not immediately relevant) experience, you can come up with innovative and creative solutions.All this experience is beneficial for developing an ai-driven patient-centered digital companion.


M7: You have recently partnered with 180 Degrees Consulting. Tell us about some developments at Oppioo that all of you are excited about
AB:
We have partnered with two great teams at 180 Degrees consulting and the London School of Economics. We are working together to get deeper market and customer insights that will be valuable in the development of both our product and business model. We are excited about the business opportunity this understanding gives us.


Limit time-wasting activities and people. Try to draw boundaries so that you can devote quality time to high-priority people and activities.



M7: What are the challenges that you face regarding handling AI technologies at Oppioo?
AB:
At Oppioo we want to improve the health of cancer patients, improve the patient experience and reduce the costs of health care. To do so, we need to work with patient data which means a lot of legal challenges. Medical data is sensitive and subject to privacy regulations that vary across jurisdictions. Companies that develop AI solutions for health care and medicine can run afoul of privacy laws if they’re not careful, and the MedTech industry is still finding the balance between access to data and protecting sensitive health data. Apart from data privacy concerns, there is also the issue of regulations. We want to be classified as a medical device to be able to give AI-driven individual healthcare advice to patients. However, it’s a time-consuming and difficult process to obtain CE marking. In fact, most of the challenges in AI are not technical applications of AI. There is the question of the quality and usability of data. In other industries, data is generally reliable and accurately measured (such as velocity data to predict highway traffic).  In healthcare, data can be subjective, and often inaccurate.


M7: What’s top of the list for what Oppioo wants to achieve by the end of this year and as you start moving into the next year?
AB:
At the end of this year, we aim to launch our product and get our first paying users. We are developing our platform together with cancer patients and health care providers to make it patient-centered. This is the biggest milestone we want to achieve and will be the start of our funding round. Next year will start with a post-product launch where we focus on understanding how well our product is accepted by end-users so that we can improve it. We will also continue building our community and expanding and strengthening our collaborations.


Diverse skills allow you to think about specific problems in a different and often more strategic way.



M7: Few years down the line, how do you see AI changing the world around us? Especially in the healthcare industry?
AB:
The future of AI in healthcare can be defined as better medical outcomes achieved through more accurate diagnosis and advanced treatment, as well as more informed and engaged patients empowered with easy access to healthcare support. AI will help us develop precision medicine and individualized healthcare with the patient in the center.  Precision health is a relatively new solution focused on preventative care which is based on patient data collected from genetic information, wearable devices and electronic health systems. Using information such as a patient’s lifestyle, genetic makeup, environment, and biometric healthcare data, AI-enabled precision health tools can identify potential risks and suggest preventative interventions.


M7: What are some of your preferred marketing channels given your target customers?
AB:
We want our users to start using Oppioo as early as possible during the cancer treatment, ideally already at the diagnosis stage. Hence Oppioo initially needs to be present where the newly diagnosed cancer patients are looking for information, such as health care providers, cancer societies, the regional or national care guides and social media groups. Therefore, established collaborations with reliable organizations and a frequent presence in social media channels are keys to our distribution chain. We are dependent on our network of collaboration partners, and every time we want to enter a market we need to find collaboration partners, such as local physiotherapists, health care providers etc. that are willing to promote the benefits of using Oppioo from an early stage of the cancer treatment.  The user can of course use Oppioo without these collaborations as well, but we believe that the best results will be reached when the user is supported by health care providers.


M7: Congratulations on being listed as one of the top ten talents in the Tech Vertical in the Swedish Nova 111-list. What is your secret to maintaining a healthy balance between work and personal life?
AB:
Thank you! I’m honored and grateful to have been included as one of the change-makers in Technology in Sweden.
My first advice is to work with something you enjoy since you spend so many hours of your day at work. But a more in-depth answer is that it’s very, very difficult to maintain a healthy balance even if you like what you work with. I think that work-life balance can be seen as a cycle, not an achievement; something to thrive for, that constantly changes with life. With that being said, I have a few life-hacks that I tend to come back to. The first is exercise and meditation.You can start small, e.g. by booking walking meetings instead of sitting in front of the computer. Ask yourself what’s currently causing you stress. Rethink your priorities, and put in time in the calendar now and then to reflect. A rational understanding of the decisions and priorities driving your life is important but equally important is emotional reflexivity - that is, the capacity to recognize how a situation is making you feel. Awareness of your emotional state is essential in order to determine the changes you want to make in your work and in your life. And last but not least: limit time-wasting activities and people. Try to draw boundaries so that you can devote quality time to high-priority people and activities. I personally like the Pomodoro Technique to help me focus.

ABOUT OPPIOO

Oppioo is a patient-centered product that supports patients to plan and execute physical activity in conjunction with the treatment plan. Oppioo predicts what activity gives optimal effect and when during the cancer treatment based on patient data and the patient’s energy level. To do so, Oppioo collects activity data from the user’s smartphone and user feedback to create a personalized automated coaching plan with the help of AI models. Oppioo allows for sharing data with health care providers.

More C-Suite on deck

Q&A with Sangram Vajre, Co-founder & Chief Evangelist at Terminus

MEDIA 7 | January 9, 2020

Sangram Vajre, Co-Founder & Chief Evangelist at Terminus is also an author and host of the podcast FlipmyFunnel. He is one of the leading minds in B2B marketing. MEDIA 7: What are you passionate about? SANGRAM VAJRE: Three things: Lead professionally. Grow personally. Love family. M7: Terminus has been recognized as one of Georgia’s 40 fastest-growing companies by ACG Atlanta. What factors contribute to this pace? SV: One of our core values is #OneTeam – which means we think and act as one team and know that if we treat our team right, they will treat our customers amazing. There are no great companies, only great people that make those companies.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Q&A with Sangram Vajre, Co-founder & Chief Evangelist at Terminus

MEDIA 7 | January 9, 2020

Sangram Vajre, Co-Founder & Chief Evangelist at Terminus is also an author and host of the podcast FlipmyFunnel. He is one of the leading minds in B2B marketing. MEDIA 7: What are you passionate about? SANGRAM VAJRE: Three things: Lead professionally. Grow personally. Love family. M7: Terminus has been recognized as one of Georgia’s 40 fastest-growing companies by ACG Atlanta. What factors contribute to this pace? SV: One of our core values is #OneTeam – which means we think and act as one team and know that if we treat our team right, they will treat our customers amazing. There are no great companies, only great people that make those companies.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Related News

FUTURE OF HEALTHCARE, MEDICAL DEVICES

Tandem Diabetes Care Successfully Acquires AMF Medical SA

Tandem Diabetes Care | January 24, 2023

On January 23, 2023, Tandem Diabetes Care, Inc., a company specializing in diabetes technology, announced that it had successfully finished acquiring AMF Medical SA, a Switzerland-based medical equipment manufacturer that created the Sigi Patch Pump. Sigi Patch Pump is a rechargeable, ergonomic patch pump intended to lower the strain of managing diabetes by utilizing pre-filled insulin cartridges. It is currently under development and is not available for retail purchase. John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care, said, "AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem's portfolio of differentiated offerings." He adds, "In addition to this innovative technology, the talented AMF team joining our Tandem family shares our commitment to simplify diabetes management and brings decades of experience from the diabetes device, life sciences, and watch-making industries." (Source – Business Wire) For this transaction, Tandem Diabetes Care received legal counsel from Baker & McKenzie LLP and Bass, Berry & Sims PLC. AMF Medical relied on SVB Securities LLC as its sole financial advisor, while Homburger AG served as its exclusive legal advisor. About Tandem Diabetes Care Headquartered in San Diego (California), Tandem Diabetes Care, Inc. is a medical device company aiming to better the lives of people with diabetes through endless innovation and a novel customer experience. The company employs a fresh and user-centric approach when it comes to developing, designing, and commercializing products for those who need to use insulin. As a result, Tandem Diabetes Care is creating a positive difference by assisting in creating better outcomes for people affected by diabetes and their healthcare providers.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

CCS Introduces Scientific Advisory Council to Advance Chronic Care Management

CCS | February 02, 2023

On February 1, 2023, CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, announced the launch of its Scientific Advisory Council, comprised of four industry leaders who will assist CCS in its commitment to reinventing patient care at home through a more holistic approach. The Council consists of Karmeen Kulkarni, MS, RD, CD, CDCES, BC-ADM; Alexander Ding, MD, MBA; Steven Wittlin, MD; and Francine Kauffman, MD. This announcement follows the appointment of Arti Masturzo, MD, as CCS's first Chief Medical Officer. Over 11% of the US population has been diagnosed with diabetes, which is projected to increase among American youth and young adults. Therefore, there is a great need for innovative technologies, partnerships, and services to fully support people in managing their diabetes. CCS chose to assemble its Scientific Advisory Council and assume a leadership position in redefining how health plans, providers, and employers support their patients and members impacted by costly, debilitating chronic diseases. Additional information about the initial members of the Council is provided below • Alexander Ding, MD, MBA, is a diagnostic and interventional radiologist, Associate VP of Physician Strategy and Medical Affairs for Humana, and an American Medical Association board member. He cultivates physician-health plan relationships and patient empowerment and engagement through digital health. • Karmeen Kulkarni, MS, CD, RD, CDCES, BC-ADM, is a clinical pioneer in diabetes management with over 30 years of experience. She was Abbott's Global Scientific Affairs director for 15 years before starting her consulting firm. Ms. Kulkarni has unique experience integrating devices, technology, coaching, and clinical services to improve outcomes for diabetes patients. • Steven Wittlin, MD, is an endocrinologist, published author, and University of Rochester's Director of Diabetes Services. His experience includes new diabetes treatment procedures that combine best practices in technology, medical devices, and clinical services. • Francine Kaufman, MD, a pediatric endocrinologist, and former American Diabetes Association president, is the Chief Medical Officer at Senseonics, Inc., and previously held that position at Medtronic Diabetes. Dr. Kaufman, a key CCS Strategic Advisory Board member, will also be on the Scientific Advisory Council. About CCS Based in Dallas, Texas, CCS provides collaborative care programs and medical supplies delivered at home for people with chronic conditions, particularly diabetes. As a result, patients have better probabilities of starting and continuing therapy with CCS as their partner, lowering costs and enhancing outcomes. The company serves over 150,000 people in the United States with chronic conditions and delivers over 1.2 million medical products to homes yearly. With over 25 years of experience, CCS has the expertise, data, and relationships to usher in a new era of home-based, proactive chronic care management.

Read More

HEALTH TECHNOLOGY

Innovaccer and UpStream Healthcare Expand Partnership to Enhance Senior Care

UpStream | January 27, 2023

On January 26, 2023, Innovaccer, Inc., a data platform for healthcare, announced that it had entered a multiyear partnership with UpStream Healthcare, a value-based primary healthcare provider solution. This partnership entails UpStream more than doubling its population on Innovaccer's cloud-native platform in the coming year, scaling its exceptional value-based care model across the U.S. In April 2022, Innovaccer announced that UpStream Healthcare had selected the Innovaccer Health Cloud, Application Suite and Data Activation Platform to speed up its mission to transform senior healthcare with a full-risk model that improves outcomes, health equity, and care costs. Medicare and Medicare Advantage members on the UpStream platform have a 20-30% lower total cost of care and a 4.5-star quality rating. The company's platform physically embeds a pharmacist-led care team in every primary care physician's office and nurses who visit Medicare-eligible seniors at home. Adding to the point-of-care clinicians, other team members will close any clinical and quality gaps to care for all seniors in full-risk financial agreements. UpStream's clinical partners range from small independent primary care practices to IPAs, with two health systems and two ACO REACH entities supported. The company's data, analytics, and population health technology must scale quickly and cost-effectively to meet growing national demand. The company's platform, powered by Innovaccer Health Cloud, seamlessly integrates with EHRs of new providers and other healthcare IT. As a result, providers can easily access integrated workflows, unified patient records, and point-of-care analytics to deliver high-quality, low-cost care. The expanded partnership follows UpStream's $140 million Series B round, raised to scale its value-based care model across the nation. Since 2018, UpStream has grown to serve over 180,000 Medicare patients and 1,000 primary care physicians in three states. About Innovaccer A California-based health cloud company, Innovaccer Inc., accelerates healthcare innovation. The Innovaccer Health Cloud unifies patient data across systems and care settings, enabling healthcare organizations to develop modern, scalable applications that improve clinical, operational, and financial outcomes. Over 1,600 U.S. care settings use Innovaccer solutions, empowering more than 96,000 providers to transform care delivery and collaborate with life sciences companies and payers. KLAS and Black Book rank Innovaccer #1 in Data and Analytics and Population Health Technology, respectively. About UpStream Headquartered in Greensboro, North Carolina, UpStream is a primary healthcare solution provider that delivers value-based care to older patients and people with chronic conditions. The company offers an all-inclusive, risk-free solution for physicians that provides, finances, and sustains better outcomes by collaborating with healthcare practices and clinics. GAP-QTM (Guaranteed Advanced Payments for Quality) is UpStream's risk-free solution for physicians. GAP-QTM benefits physicians and practices by increasing income, professional satisfaction, and patients by lowering hospitalizations, decreasing copayments, and providing better benefits.

Read More

FUTURE OF HEALTHCARE, MEDICAL DEVICES

Tandem Diabetes Care Successfully Acquires AMF Medical SA

Tandem Diabetes Care | January 24, 2023

On January 23, 2023, Tandem Diabetes Care, Inc., a company specializing in diabetes technology, announced that it had successfully finished acquiring AMF Medical SA, a Switzerland-based medical equipment manufacturer that created the Sigi Patch Pump. Sigi Patch Pump is a rechargeable, ergonomic patch pump intended to lower the strain of managing diabetes by utilizing pre-filled insulin cartridges. It is currently under development and is not available for retail purchase. John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care, said, "AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem's portfolio of differentiated offerings." He adds, "In addition to this innovative technology, the talented AMF team joining our Tandem family shares our commitment to simplify diabetes management and brings decades of experience from the diabetes device, life sciences, and watch-making industries." (Source – Business Wire) For this transaction, Tandem Diabetes Care received legal counsel from Baker & McKenzie LLP and Bass, Berry & Sims PLC. AMF Medical relied on SVB Securities LLC as its sole financial advisor, while Homburger AG served as its exclusive legal advisor. About Tandem Diabetes Care Headquartered in San Diego (California), Tandem Diabetes Care, Inc. is a medical device company aiming to better the lives of people with diabetes through endless innovation and a novel customer experience. The company employs a fresh and user-centric approach when it comes to developing, designing, and commercializing products for those who need to use insulin. As a result, Tandem Diabetes Care is creating a positive difference by assisting in creating better outcomes for people affected by diabetes and their healthcare providers.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

CCS Introduces Scientific Advisory Council to Advance Chronic Care Management

CCS | February 02, 2023

On February 1, 2023, CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, announced the launch of its Scientific Advisory Council, comprised of four industry leaders who will assist CCS in its commitment to reinventing patient care at home through a more holistic approach. The Council consists of Karmeen Kulkarni, MS, RD, CD, CDCES, BC-ADM; Alexander Ding, MD, MBA; Steven Wittlin, MD; and Francine Kauffman, MD. This announcement follows the appointment of Arti Masturzo, MD, as CCS's first Chief Medical Officer. Over 11% of the US population has been diagnosed with diabetes, which is projected to increase among American youth and young adults. Therefore, there is a great need for innovative technologies, partnerships, and services to fully support people in managing their diabetes. CCS chose to assemble its Scientific Advisory Council and assume a leadership position in redefining how health plans, providers, and employers support their patients and members impacted by costly, debilitating chronic diseases. Additional information about the initial members of the Council is provided below • Alexander Ding, MD, MBA, is a diagnostic and interventional radiologist, Associate VP of Physician Strategy and Medical Affairs for Humana, and an American Medical Association board member. He cultivates physician-health plan relationships and patient empowerment and engagement through digital health. • Karmeen Kulkarni, MS, CD, RD, CDCES, BC-ADM, is a clinical pioneer in diabetes management with over 30 years of experience. She was Abbott's Global Scientific Affairs director for 15 years before starting her consulting firm. Ms. Kulkarni has unique experience integrating devices, technology, coaching, and clinical services to improve outcomes for diabetes patients. • Steven Wittlin, MD, is an endocrinologist, published author, and University of Rochester's Director of Diabetes Services. His experience includes new diabetes treatment procedures that combine best practices in technology, medical devices, and clinical services. • Francine Kaufman, MD, a pediatric endocrinologist, and former American Diabetes Association president, is the Chief Medical Officer at Senseonics, Inc., and previously held that position at Medtronic Diabetes. Dr. Kaufman, a key CCS Strategic Advisory Board member, will also be on the Scientific Advisory Council. About CCS Based in Dallas, Texas, CCS provides collaborative care programs and medical supplies delivered at home for people with chronic conditions, particularly diabetes. As a result, patients have better probabilities of starting and continuing therapy with CCS as their partner, lowering costs and enhancing outcomes. The company serves over 150,000 people in the United States with chronic conditions and delivers over 1.2 million medical products to homes yearly. With over 25 years of experience, CCS has the expertise, data, and relationships to usher in a new era of home-based, proactive chronic care management.

Read More

HEALTH TECHNOLOGY

Innovaccer and UpStream Healthcare Expand Partnership to Enhance Senior Care

UpStream | January 27, 2023

On January 26, 2023, Innovaccer, Inc., a data platform for healthcare, announced that it had entered a multiyear partnership with UpStream Healthcare, a value-based primary healthcare provider solution. This partnership entails UpStream more than doubling its population on Innovaccer's cloud-native platform in the coming year, scaling its exceptional value-based care model across the U.S. In April 2022, Innovaccer announced that UpStream Healthcare had selected the Innovaccer Health Cloud, Application Suite and Data Activation Platform to speed up its mission to transform senior healthcare with a full-risk model that improves outcomes, health equity, and care costs. Medicare and Medicare Advantage members on the UpStream platform have a 20-30% lower total cost of care and a 4.5-star quality rating. The company's platform physically embeds a pharmacist-led care team in every primary care physician's office and nurses who visit Medicare-eligible seniors at home. Adding to the point-of-care clinicians, other team members will close any clinical and quality gaps to care for all seniors in full-risk financial agreements. UpStream's clinical partners range from small independent primary care practices to IPAs, with two health systems and two ACO REACH entities supported. The company's data, analytics, and population health technology must scale quickly and cost-effectively to meet growing national demand. The company's platform, powered by Innovaccer Health Cloud, seamlessly integrates with EHRs of new providers and other healthcare IT. As a result, providers can easily access integrated workflows, unified patient records, and point-of-care analytics to deliver high-quality, low-cost care. The expanded partnership follows UpStream's $140 million Series B round, raised to scale its value-based care model across the nation. Since 2018, UpStream has grown to serve over 180,000 Medicare patients and 1,000 primary care physicians in three states. About Innovaccer A California-based health cloud company, Innovaccer Inc., accelerates healthcare innovation. The Innovaccer Health Cloud unifies patient data across systems and care settings, enabling healthcare organizations to develop modern, scalable applications that improve clinical, operational, and financial outcomes. Over 1,600 U.S. care settings use Innovaccer solutions, empowering more than 96,000 providers to transform care delivery and collaborate with life sciences companies and payers. KLAS and Black Book rank Innovaccer #1 in Data and Analytics and Population Health Technology, respectively. About UpStream Headquartered in Greensboro, North Carolina, UpStream is a primary healthcare solution provider that delivers value-based care to older patients and people with chronic conditions. The company offers an all-inclusive, risk-free solution for physicians that provides, finances, and sustains better outcomes by collaborating with healthcare practices and clinics. GAP-QTM (Guaranteed Advanced Payments for Quality) is UpStream's risk-free solution for physicians. GAP-QTM benefits physicians and practices by increasing income, professional satisfaction, and patients by lowering hospitalizations, decreasing copayments, and providing better benefits.

Read More

Spotlight

Oppioo

Oppioo

Oppioo is a patient-centered product that supports patients to plan and execute physical activity in conjunction with the treatment plan. Oppioo predicts what activity gives optimal effect and when during the cancer treatment based on patient data and the patient’s energy level. To do so, Oppioo col...

Events

Resources